stella
beta
Evaluation of the Efficacy and Safety of Pazopanib in Combination with TGI/CIV for Recurrent or Refractory Rhabdomyosarcoma in Children or Adolescents — Stella
Recruiting
Back to Rhabdomyosarcoma, Recurrent, Refractory trials
Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations
(1 site)
China
No. 440 Jiyan Road, Jinan City, Shandong Province, Jinan, Shandong
View full record on ClinicalTrials.gov